Showing 1321-1330 of 2192 results for "".
- What Should We Do About Asymptomatic AVMs?https://practicalneurology.com/columns/practice-management/what-should-we-do-about-asymptomatic-avms/31127/Clinical Decision-Making in the Management of Asymptomatic Cerebral Arteriovenous MalformationsCerebral arteriovenous malformations (AVMs) present a significant clinical challenge, especially when asymptomatic. The primary dilemma revolves around balancing the natural hemorrhage risk against the pot
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31247/Recent developments in the treatment of high-grade carotid stenosis have intensified interest in carotid artery stenting (CAS) as an alternative to the traditional carotid endarterectomy (CEA). The FDA has approved CAS for patients with symptomatic carotid stenosis who are deemed high-risk for conve
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31291/Recent advancements in stroke prevention have been scrutinized through pivotal clinical trials, providing critical insights for healthcare professionals. Last month, the ACTIVE, CHARISMA, and MATCH trials collectively assessed the efficacy of combining aspirin with clopidogrel in over 25,000 stroke
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31309/Recent large-scale trials have cast doubt on the efficacy of combination antiplatelet therapies, such as clopidogrel (Plavix) plus aspirin or dipyridamole plus aspirin (Aggrenox), for secondary stroke prevention in high-risk patients. Historically, these combinations were favored over aspirin alone
- Income Survey: Surviving the Storm, Steering to Safetyhttps://practicalneurology.com/columns/practice-management/income-survey-surviving-the-storm-steering-to-safety/31315/Income Trends and Challenges in Neurology PracticesA May 2006 issue of *Practical Neurology* presents findings from the fifth annual income survey, highlighting evolving financial dynamics within neurology practices. Over the past decade, neurologists have grappled with declining third-party reimbur
Therapeutics Q&A: How Many AEDs are Optimal for Pediatric Epilepsy Management?
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/therapeutics-qa-how-many-aeds-are-optimal-for-pediatric-epilepsy-management/30831/A recent study sheds light on the benefits and limitations of multi-AED therapy in children with intractable epilepsy.Case Conference: The “Noise” of Medicine
https://practicalneurology.com/diseases-diagnoses/imaging-testing/case-conference-the-noise-of-medicine/31929/There is great promise—and also pitfalls—of using checklists to improve diagnostic accuracy in medicine.Movement Disorders Moment: Neuropsychiatric Symptoms in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-neuropsychiatric-symptoms-in-parkinson-disease/31880/Broader awareness and assessment of neuropsychiatric symptoms are needed.Tuberculous Radiculomyelitis
https://practicalneurology.com/diseases-diagnoses/imaging-testing/tuberculous-radiculomyelitis/32030/A rare complication of central nervous system tuberculosis- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31323/Insurance denials significantly impact neurology practices, often leading to a 3-5% loss in net revenue. Given that neurology services predominantly involve office-based evaluations and management requiring managed care referrals, addressing these denials is crucial for financial stability. High pat